The rise in the obese population, the rise in the prevalence of chronic diseases that require endoscopy devices, shorter recovery times and minimal post-operative...
The Food and Drug Administration on Friday approved oral dapagliflozin (Farxiga) tablets to slow the progression of chronic kidney disease in adults with and...
This article was originally published here
Pediatr Neurol. 2021, April 2; 120: 7-10. doi: 10.1016 / j.pediatrneurol.2021.03.007. Online before printing.
ABSTRACT
BACKGROUND: Tuberous...